TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK. TRAKIA JOURNAL OF SCIENCES, [S. l.], v. 23, n. Supplement 1, p. 6, 2025. DOI: 10.15547/tjs.2025.s.01.004. Disponível em: https://tjs.trakia-uni.bg/index.php/tjs/article/view/143.. Acesso em: 22 oct. 2025.